Source: Annual Congress 2013 –Introduction to endoscopic lung volume reduction with RePneu LVR coils



Rating:

Share or cite this content

Citations should be made in the following way:
P. Shah (London, United Kingdom). Mechanism of action and high-level overview of clinical results. Annual Congress 2013 –Introduction to endoscopic lung volume reduction with RePneu LVR coils

Member's Comments

No comment yet.

Related content which might interest you: Mechanism of action & high-level overview of clinical results Source: International Congress 2014 – Hands-on practice with coils for treatment of advanced emphysema Year: 2014 Clinical and translational research: an overview Source: ERS Course 2015 Year: 2015 Characterisation of clinical phenotypes is mandatory for the development of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Historical overview: On the evolution of respiratory support for neonates Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009 Pirfenidone: an update on clinical trial data and insights from everyday practice Source: Eur Respir Rev 2014; 23: 111-117 Year: 2014 Respiratory monitoring: revisiting classical physiological principles with new tools Source: Eur Respir J 2004; 24 : 718-719 Year: 2004 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Late Breaking Abstract - Evidence of target engagement and pathway modulation: biomarker analysis of the phase 1b inhaled seralutinib study Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 CPET overview: clinical usefulness and limitations Source: ERS Skills course - Clinical exercise testing: advanced Year: 2018 Translation of in vitro findings to patients with asthma: a timely and compelling challenge Source: Eur Respir J, 54 (4) 1901759; 10.1183/13993003.01759-2019 Year: 2019 How to accelerate bringing new drugs to patients: role of clinical trials networks Source: International Congress 2019 – Rare lung diseases Year: 2019 General overview of system biology and network analysis Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008